Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
The nurse is caring for a client who is being evaluated for possible deep vein thrombosis of the right extremity. Which laboratory result is of most concern to the nurse?
A. Activated Partial Thromboplastin Time (aPTT) of 25.
Activated Partial Thromboplastin Time (aPTT) of 25 is within the normal range (25-35 seconds) and is not directly related to deep vein thrombosis (DVT)89.
B. D-dimer of 500 ng/mL.
A D-dimer level of 500 ng/mL is elevated (normal range is typically less than 250 ng/mL), which can indicate the presence of a clot, such as in DVT8910.
C. Prothrombin Time (PT) of 14 seconds.
Prothrombin Time (PT) of 14 seconds is within the normal range (11-13.5 seconds) and is not directly related to DVT89.
D. Platelet count of 148,000 uL.
A platelet count of 148,000 uL is within the normal range (150,000-450,000 uL) and is not directly related to DVT89.
This question is an excerpt from Nurse Dive's nursing test bank - Ati Med Surg Nurs 200 Proctored Exam Roxoborouh Memorial College. Take the full exam now
Full Explanation
Choice A rationale
Activated Partial Thromboplastin Time (aPTT) of 25 is within the normal range (25-35 seconds) and is not directly related to deep vein thrombosis (DVT)89.
Choice B rationale
A D-dimer level of 500 ng/mL is elevated (normal range is typically less than 250 ng/mL), which can indicate the presence of a clot, such as in DVT8910.
Choice C rationale
Prothrombin Time (PT) of 14 seconds is within the normal range (11-13.5 seconds) and is not directly related to DVT89.
Choice D rationale
A platelet count of 148,000 uL is within the normal range (150,000-450,000 uL) and is not directly related to DVT89.
Similar Questions
A patient receives 20 units of Isophane Insulin Suspension (NPH) Insulin at 07:30. At what time are signs of hypoglycemia most likely to occur?
A. 08:30
B. 10:30
C. 14:30
Step 1: NPH insulin generally starts to act within 1 to 3 hours after injection. Step 2: Its peak effect occurs 4 to 12 hours after injection. Step 3: If the patient receives the insulin at 07:30, the peak effect would be between 11:30 (07:30 + 4 hours) and 19:30 (07:30 + 12 hours). Step 4: Hypoglycemia is most likely to occur during the peak effect of the insulin, which is between 11:30 and 19:30. Step 5: Among the given options, 14:30 falls within this range.
D. 23:00 .
A patient diagnosed with peripheral arterial disease is being educated about the benefits of walking for exercise. What information should the nurse emphasize?
A. Elevate the feet for 30 minutes after walking.
Elevating the feet for 30 minutes after walking is not specifically beneficial for a patient with peripheral arterial disease (PAD). While elevation can help with conditions like edema, it does not directly address the issues associated with PAD12.
B. Avoid exercise that increases the heart rate.
Avoiding exercise that increases the heart rate is not the best advice for a patient with PAD. Exercise, including activities that increase heart rate, can actually be beneficial. It can help improve circulation, which is often compromised in PAD12.
C. Continue walking to the point of pain.
Continuing to walk to the point of pain is beneficial for patients with PAD. Walking, especially at a high intensity, can help improve symptoms of PAD. It can increase blood flow and oxygen supply to the muscles, which can help manage PAD symptoms.
D. Do not walk if a leg ulcer develops.
While it’s important to care for any ulcers that develop and seek medical attention, stopping walking altogether if a leg ulcer develops is not necessary. Walking is a low-impact activity that can help improve mobility over time.
Full Explanation
Choice A rationale
Elevating the feet for 30 minutes after walking is not specifically beneficial for a patient with peripheral arterial disease (PAD). While elevation can help with conditions like edema, it does not directly address the issues associated with PAD12.
Choice B rationale
Avoiding exercise that increases the heart rate is not the best advice for a patient with PAD. Exercise, including activities that increase heart rate, can actually be beneficial. It can help improve circulation, which is often compromised in PAD12.
Choice C rationale
Continuing to walk to the point of pain is beneficial for patients with PAD. Walking, especially at a high intensity, can help improve symptoms of PAD. It can increase blood flow and oxygen supply to the muscles, which can help manage PAD symptoms.
Choice D rationale
While it’s important to care for any ulcers that develop and seek medical attention, stopping walking altogether if a leg ulcer develops is not necessary. Walking is a low-impact activity that can help improve mobility over time.
The nurse is explaining to a patient why oral antihyperglycemic agents are not effective in Type 1 diabetes. What is the reason?
A. People with Type 1 diabetes have little or none of their own insulin that can be released.
People with Type 1 diabetes have little or no insulin that can be released. This is because their pancreatic β-cells, which produce insulin, are destroyed by an autoimmune process. Without insulin, glucose cannot be taken up into cells to be used for energy. Oral antihyperglycemic agents work by increasing the release of insulin or increasing the body’s sensitivity to insulin, so they are not effective in Type 1 diabetes where there is an absolute insulin deficiency.
B. People with Type 1 diabetes would need so much of an oral antihyperglycemic agent that it would cost too much.
The cost of oral antihyperglycemic agents is not the primary reason they are not used in Type 1 diabetes. The main issue is the lack of insulin production, which these medications cannot address.
C. People with Type 1 diabetes have resistance to their endogenous insulin.
People with Type 1 diabetes do not typically have resistance to their endogenous insulin. Insulin resistance is more commonly associated with Type 2 diabetes.
D. People with Type 1 diabetes would have more episodes of hypoglycemia with oral antihyperglycemic agents.
While hypoglycemia can occur with the use of some antihyperglycemic agents, this is not the primary reason these medications are not used in Type 1 diabetes. The main issue is the absolute deficiency of insulin.
Full Explanation
Choice A rationale
People with Type 1 diabetes have little or no insulin that can be released. This is because their pancreatic β-cells, which produce insulin, are destroyed by an autoimmune process. Without insulin, glucose cannot be taken up into cells to be used for energy. Oral antihyperglycemic agents work by increasing the release of insulin or increasing the body’s sensitivity to insulin, so they are not effective in Type 1 diabetes where there is an absolute insulin deficiency.
Choice B rationale
The cost of oral antihyperglycemic agents is not the primary reason they are not used in Type 1 diabetes. The main issue is the lack of insulin production, which these medications cannot address.
Choice C rationale
People with Type 1 diabetes do not typically have resistance to their endogenous insulin. Insulin resistance is more commonly associated with Type 2 diabetes.
Choice D rationale
While hypoglycemia can occur with the use of some antihyperglycemic agents, this is not the primary reason these medications are not used in Type 1 diabetes. The main issue is the absolute deficiency of insulin.